期刊文献+

综合干预措施对类风湿关节炎患者生存质量的影响 被引量:12

Assessment of the Quality of Life in Patients with Rheumatoid Arthritis Receiving Characteristic Therapy of Traditional Chinese Medicine
下载PDF
导出
摘要 目的:比较在非甾体消炎镇痛药和甲氨蝶呤基础上,应用中药内服、外敷兼康复训练对类风湿关节炎(RA)病人生存质量变化的影响,旨在科学评价RA治疗方案中综合干预措施的可行性和必要性。方法:80例病例来源于随机对照临床试验,以RA生活质量量表作为本研究测量的工具。结果:综合干预组治疗RA总有效率为91.7%,优于西药对照组(P<0.05);综合干预组治疗前后患者生理、心理、社会功能、健康自我认识分值较治疗前水平明显改善(P<0.01),优于西药对照组(P<0.05)。结论:综合干预措施治疗类风湿关节炎疗效佳,使RA患者有更高的生活质量。 Objective:To assess the quality of life (QoL) in rheumatoid arthritis (RA) patients with 3 -month character- istic therapy of traditional Chinese medicine (TCM) plus NSAIDs (nonsteroidal anti - inflammatory drugs) and metho- trexate (MTX) for reducing deformity and disability, comparing with NSAIDs and MTX alone. Method:The research design was a randomized controlled trial. The questionnaire for assessment of QoL in RA patients was established and published. Results:The total effective rate of TCM treatment group was 91.7%, which exceeded remarkably compared with the control group(P 〈0.05); After treatment of the TCM characteristic therapy, the physical, social, emotional function, self- recognized health status of RA patients improved significantly( P 〈 0.01 ), and the effects exceeded com- pared with that of control group(P 〈0.05 ). Conclusion:Characteristic therapy of traditional Chinese medicine is effec- tive for the patients with rheumatoid arthritis in the improvement of quality of life, and the effect is better than that of control group.
出处 《中医药学报》 CAS 2012年第3期81-83,共3页 Acta Chinese Medicine and Pharmacology
关键词 类风湿 中药 康复训练 综合干预措施 生存质量 Rheumatoid arthritis characteristic therapy of traditional Chinese medicine Quality of life
  • 相关文献

参考文献13

二级参考文献26

  • 1费立鹏 Henderson G.医学社会科学的临床应用:医学社会科学在临床科研的设计和评价中的使用[M].上海临床流行病中心,1997..
  • 2[1]Arnett FC,Edworthy SM,Bloth DA,et al.The 1987 revised ARA criteria for rheumatoid arthritis (RA)[J].Arthritis Rheum,1987,30(17):45.
  • 3Stuart JM, CremerMA, TownesAS, et al. Type Ⅱ collagen - induced arthritis in rats. Passive transferwith serum and evidence that IgG anticollagen antibodies can cause arthritis [ J ]. ExpMed, 1982,155 ( 1 ) : 1 -16.
  • 4Yuan GH, Masuko - ttongo K, Nishioka K. Role of chemokines/chemokine receptor systems in cartilage degradation[ J]. Drug News Perspec,2001,10:591 - 600.
  • 5Cho ML,Yoou BY, Ju JH, et al. Expression of CCR2A, an isoform of MCP- 1 receptor,is increased by MCP -1, CD40 ligand and TGF - beta in fibroblast like svuoviocvtes of patients with RA[ J]. Exp Mol Med ,2007,39:499 - 507.
  • 6Yousse fS, Maor G, Wildbaum G, et al. c - c chem okine - encoding DNA vaccines breakdown of tolerance to their gene products and treat on going and iuvah tarthritis[ J ]. JC lin In vest,2000,106:361 - 37l.
  • 7G ongJH, R atkay LG, W aterfield JD, et al. An aniagonistofm onocytechemo attraciantprotein( MCP - 1 ) inhibits arthritis in the M RI - lpr mouse model [ J ]. JExp Med, 1997,186 : 131 - 137.
  • 8娄玉伶.中国风湿病学[M].北京:人民卫生出版社,2001.3153-7.
  • 9费立鹏,医学社会科学的临床应用.医学社会科学在临床科研的设计和评价中的使用,1997年
  • 10Gonzales V, Goeppinger J, Lorig K. Four psychological theories and their application to patient education and clinical practice [ J ].Arthritis Care Research, 1990,3 : 132 - 143.

共引文献162

同被引文献127

引证文献12

二级引证文献80

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部